Agilent | A - Umsatzerlöse

Aktienkurs
112.11
Täglich Wechseln
0.41 0.37%
Monatlich
-7.32%
Jährlich
-1.17%
Q2 Prognose
109.45




Der Umsatz Veränderung Datum
Abbott USD 11.16B 300M 2026-03
Agilent USD 1.8B 63M 2025-12
Align Technology USD 1.04B 10M 2026-03
Bio Techne USD 311.4M 15.5M 2026-03
Bio-Rad Laboratories USD 592.1M 101.1M 2026-03
Bruker USD 823.4M 153.8M 2026-03
Charles River Laboratories USD 995.8M 1.6M 2026-03
Danaher USD 5.95B 890M 2026-03
Dentsply International USD 880M 81M 2026-03
Edwards Lifesciences USD 1.65B 80M 2026-03
Henry Schein USD 3.37B 30M 2026-03
Illumina USD 1.09B 70M 2026-03
Intuitive Surgical USD 2.77B 100M 2026-03
IQVIA Holdings USD 4.15B 210M 2026-03
Laboratory Of America USD 3.54B 20M 2026-03
Mettler Toledo International USD 947.13M 182.87M 2026-03
Myriad Genetics USD 200.4M 9.4M 2026-03
OraSure Technologies USD 26.76M 322K 2025-12
Quest Diagnostics USD 2.9B 90M 2026-03
Quidel USD 620M 104M 2026-03
Repligen USD 194M 3.91M 2026-03
Revvity USD 711M 61.06M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Thermo Fisher Scientific USD 11.01B 1.2B 2026-03
Waters USD 1.27B 338M 2026-03
Zimmer Biomet Holdings USD 2.09B 150M 2026-03